INPLASY202550089 Treatment strategy for advanced or metastatic NSCLC patients with EGFR mutations after TKI-resistance: A scoping review Keywords: Non-small cell lung cancer; Treatment strategy; EGFR mutations; TKI-resistance; Scoping review. Read and download full-text here - PDF 202550089 Review Status: ongoing
